国产BuMA支架在冠心病大小血管病变经皮冠状动脉介入治疗中的疗效比较Comparison of therapeutic effects of biodegradable drug-eluting stent between big and small coronary artery lesions in patients receiving interventional therapy
孙月玲,苑淑丽,孙波,冯福宾
摘要(Abstract):
目的评价国产BuMA生物降解药物涂层冠状动脉支架在冠心病小血管病变经皮冠状动脉介入治疗中的临床疗效及安全性。方法选择182例行经皮冠状动脉介入治疗(PCI)的冠心病患者,其中小血管病变组102例,大血管病变组80例,均置入BuMA生物降解药物涂层冠状动脉支架,比较观察手术成功率、术中并发症及在1~12个月随访期间的心绞痛、猝死、主要不良心脏事件(MACE)发生率及复查冠状动脉造影情况。结果大血管病变组和小血管病变组手术即刻成功率均为100%,两组共发现203处靶病变,共置入支架273枚。术中均无严重并发症发生。对入选182例患者进行出院后第1、3、6、12个月门诊随访发现,小血管病变组8例心绞痛复发,其中1例为糖尿病患者。大血管病变组5例复发心绞痛。于术后第6~9个月复查冠状动脉造影证实,小血管病变组2例分别为右冠状动脉主干、左前降支支架内远段再狭窄达75%~80%,大血管病变组1例为左前降支支架近端再狭窄75%。两组心绞痛复发、冠状动脉造影支架内再狭窄及靶病变血运重建主要MACE发生率的差异均无统计学意义。两组均未出现迟发性支架内血栓、无心肌梗死及猝死。结论国产BuMA生物降解药物涂层冠状动脉支架应用于冠心病小血管病变介入治疗安全、有效,疗效不逊于用于冠心病大血管病变时。
关键词(KeyWords): 冠心病;小血管;大血管;介入治疗;BuMA生物降解药物涂层冠状动脉支架
基金项目(Foundation):
作者(Author): 孙月玲,苑淑丽,孙波,冯福宾
参考文献(References):
- [1]Mehilli J,Kastrati A,Dirschinger J,et al.Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus.Am J Med,2002,112:13-18.
- [2]Savage MP,Fischman DL,Rake R,et al.Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries.Stent Restenosis Study(STRESS)Investigators.J Am Cardiol,1998,31:307-311.
- [3]Colombo A,Hall P,Nakamura s,et a1.Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.circulation,1995,9l:1676-1688.
- [4]韩雅玲,荆全民,王守力,等.直接冠状动脉支架置入术的前瞻性临床研究.中华心血管病杂志,2002,30:265-268.
- [5]王羽,赵明钢,霍勇,等.卫生部心血管疾病介入诊疗技术培训教材冠心病分册.北京:卫生部医政司,2009:154.
- [6]Lemos PA,Saia F,Hofma SH,et al.Short and long-term clinical benefitof sirolimus-eluting sents compared to conventional bare stents for patients with acute myocardial infarction.J Am Coll Cardiol,2004,43:704-708.
- [7]Dangas GD,Claessen BE,Caixeta A,et al.In-stent restenosis in the drug-eluting stent era.J Am Coll Cardiol,2010,56:1897-1907.
- [8]Schofer J,Schlüter M,Gershlick AH,et al.Sirolmuselu ting stens for treatmentof patientswith long atherosclerotic lesions in small coronary arteries:double-blind,randomised controlled trial(E-SIRIUS).Lancet,2003,362:1093-1099.
- [9]Rodriguez AE,Rodriguez Alemparte M,Fernandez Pereira C,et al.Latin American randomized trial of balloon angiop lasty versus coronary stenting in diabetic patientswith small vessel reference size[LatinAmerican Small Vessel(LASMALⅡ)Trial]:mi mediate and long-term results.Am Heart J,2005,150:188.
- [10]Ong AT,Serruys PW.Technology insigh:t an overview of research in drug-eluting stents.Nat Clin Pract Cardiovasc Med,2005,2:647-658.
- [11]刘长福,陈韵岱,陈练等.光学相干断层成像评价国产新型药物洗脱支架术后内膜增殖.南方医科大学学报,2010,30:1063-1065.
- [12]杨丽霞,齐峰,王红,等.赵颖国产新型可生物降解药物洗脱支架临床应用212例.中国介入心脏病学杂志,2008,16:73-76.
- [13]Nakazawa G,Nakano M,Otsuka F,et al.Evaluation of polymerbased comparator drug-eluting stents using a rabbit model of iliacartery atherosclerosis.Circ Cardiovasc Interv,2011,4:38-46.